Severe Eczema Drug Is Approved by F.D.A.; Price Tag Is $37,000 a Year The drug makers Regeneron Pharmaceuticals and Sanofi made a rare move, negotiating with insurers in advance over the price for Dupixent. Share: Facebook Twitter Google+ Stumble Digg Email ThisBlogThis!Share to XShare to Facebook Related Posts:The New Health Care: Why the Medical Research Grant System Could Be Costing Us Great IdeasIt Was Supposed to Be an Unbiased Study of Drinking. They Wanted to Call It ‘Cheers.’Are Genetic Testing Sites the New Social Networks?A Family in TransitionLIFE ON MOON: Water discovered on Moon – and it could be enough to sustain a colonyAddo Dispatch: Where Female Elephants Without Tusks Roam — and Poachers Stay Away
